Compare
Strata Critical Medical, Inc. vs DocGo Inc. vs Lindblad Expeditions Holdings, Inc. vs MingZhu Logistics Holdings Ltd
| Latest fiscal year | Strata Critical Medical, Inc. SRTA | DocGo Inc. DCGO | Lindblad Expeditions Holdings, Inc. LIND | MingZhu Logistics Holdings Ltd YGMZFLast annual report: year ended 2024-12-31 |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2024-12-31 |
| Revenue | $197.14M | $322.20M | $771.02M | $40.43M |
| Revenue growth (YoY) | +34.3% | -47.7% | +19.6% | -54.6% |
| Gross margin | 20.9% | n/a | 45.8% (computed) | n/a |
| Operating margin | -11.3% | -55.3% | 5.9% | -10.0% |
| Net margin | 21.0% | -56.6% | -3.9% | -15.3% |
| Net income | $41.35M | -$182.40M | -$29.72M | -$6.19M |
| EPS (Diluted) | $0.50 | -$1.84 | -$0.63 | -$1.31 |
| Operating cash flow | -$48.91M | $34.45M | $111.58M | -$2.59M |
| Free cash flow | -$58.51M | $29.91M | $63.84M | -$2.70M |
| Cash & equivalents | $30.97M | $51.02M | $256.69M | $698.2K |
| Total assets | $325.47M | $217.10M | $979.96M | $90.33M |
| Total liabilities | $46.40M | $91.23M | $1.13B | $45.58M |
| Shareholders' equity | $279.07M | $144.01M | -$284.53M | $44.75M |
| Return on year-end equity | 14.8% | -126.7% | n/a | -13.8% |
| Shares outstanding | n/a | 98.64M | 55.32M | 6.68M |
Revenue, most recent five fiscal years
| Fiscal year | Strata Critical Medical, Inc. | DocGo Inc. | Lindblad Expeditions Holdings, Inc. | MingZhu Logistics Holdings Ltd |
|---|---|---|---|---|
| Latest | $197.14M Ended 2025-12-31 | $322.20M Ended 2025-12-31 | $771.02M Ended 2025-12-31 | $40.43M Ended 2024-12-31 |
| 1 year earlier | $146.82M Ended 2024-12-31 | $616.56M Ended 2024-12-31 | $644.73M Ended 2024-12-31 | $89.00M Ended 2023-12-31 |
| 2 years earlier | $225.18M Ended 2023-12-31 | $624.29M Ended 2023-12-31 | $569.54M Ended 2023-12-31 | $63.52M Ended 2022-12-31 |
| 3 years earlier | $146.12M Ended 2022-12-31 | $440.52M Ended 2022-12-31 | $421.50M Ended 2022-12-31 | $17.36M Ended 2021-12-31 |
| 4 years earlier | n/a | $318.72M Ended 2021-12-31 | $147.11M Ended 2021-12-31 | $18.79M Ended 2020-12-31 |